The Drugs Control Administration (DCA) in Telangana took decisive action on Saturday against the falsification of drug licenses by Ovoid Pharmachem Pvt Ltd, a pharmaceutical company situated in Jeedimetla. A case has been lodged against the company director.
According to an official statement from the DCA, a complaint has been filed at the Jeedimetla Police Station concerning the falsification of a drug license. Narasapally Ramudu, Director of Ovoid Pharmachem Pvt Ltd, is facing charges under Sections 420 (Cheating) and 468 (Forgery) of the Indian Penal Code (IPC) in FIR No. 327/2024, filed on May 5, 2024, at the Jeedimetla Police Station.
The allegations involve the creation of a counterfeit drug license containing unauthorized drug products not approved by the DCA, Telangana, as well as the production and sale of goods under the forged drug license. This incident highlights a significant case of fraudulent activity within the pharmaceutical sector, as uncovered by an investigation conducted by DCA officials, revealing misconduct at Ovoid Pharmachem Pvt Ltd, located at Plot No. 318, Subashnagar, Quthbullapur Mandal, Medchal-Malkajgiri District.
READ MORE
New York City Will Pay A Massive $17.5 Million Over Forcing Women To Remove Hijab For Mug Shots
Narasapally Ramudu, Director of Ovoid Pharmachem Pvt Ltd, was found involved in fabricating a counterfeit Drug Manufacturing license for unauthorized drug products, deceiving regulatory authorities and endangering public health.
Upon verification by the Drugs Control Administration, Telangana’s licensing database, it was confirmed that Ovoid Pharmachem Pvt Ltd had forged a drug license. Furthermore, the firm was discovered manufacturing and selling certain drugs under this fraudulent license. Officials seized stocks valued at Rs 23.93 lakhs, including 800 Kgs of Activated Charcoal 250 mg and Simethicone 80 mg Pellets.
This illicit activity poses a grave risk to public health and safety. Manufacturers must adhere strictly to regulatory standards and ethical conduct. The Drugs Control Administration, Telangana, has issued a stern warning to all pharmaceutical manufacturers and stakeholders regarding the serious consequences of forging drug licenses. Any individuals or firms found engaging in such illegal activities will face severe repercussions.
